Peroxisome proliferator-activated receptors as stimulants of angiogenesis in cardiovascular disease and diabetes

References

• WeeCCHamelMBHuangADavisRBMittlemanMAMcCarthyEPObesity and undiagnosed diabetes in the USDiabetes Care2008311813181518509212
   PubMed Web of Science ®Google Scholar
• WestphalSAObesity, abdominal obesity, and insulin resistanceClin Cornerstone20089233119046737
   PubMedGoogle Scholar
• CalkinACThomasMCPPAR agonists and cardiovascular disease in diabetesPPAR Res2008245410
   Google Scholar
• DuanSZIvashchenkoCYUsherMGMortensenRMPPAR-gamma in the cardiovascular systemPPAR Res2008745804
   Google Scholar
• KnouffCAuwerxJPeroxisome proliferator-activated receptor-gamma calls for activation in moderation: lessons from genetics and pharmacologyEndocr Rev20042589991815583022
   PubMed Web of Science ®Google Scholar
• ErdmannEDormandyJWilcoxRMassi-BenedettiMCharbonnelBPROactive 07: pioglitazone in the treatment of type 2 diabetes: results of the PROactive studyVasc Health Risk Manag2007335537017969365
   PubMedGoogle Scholar
• NissenSEWolskiKEffect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causesN Engl J Med20073562457247117517853
   PubMed Web of Science ®Google Scholar
• FolkmanJAngiogenesis in cancer, vascular, rheumatoid and other diseaseNat Med1995127317584949
   PubMed Web of Science ®Google Scholar
• CarmelietPBaesMMetabolism and therapeutic angiogenesisN Engl J Med20083582511251218525050
   PubMed Web of Science ®Google Scholar
• MartinAKomadaMRSaneDCAbnormal angiogenesis in diabetes mellitusMed Res Rev20032311714512500286
   PubMed Web of Science ®Google Scholar
• SimonsMAngiogenesis, arteriogenesis, and diabetes: paradigm reassessed?J Am Coll Cardiol20054683583716139133
   PubMed Web of Science ®Google Scholar
• QaumTXuQJoussenAMVEGF-initiated blood-retinal barrier breakdown in early diabetesInvest Ophthalmol Vis Sci2001422408241311527957
   PubMed Web of Science ®Google Scholar
• PitchfordSCFurzeRCJonesCPWengnerAMRankinSMDifferential mobilization of subsets of progenitor cells from the bone marrowCell Stem Cell20094627219128793
   PubMed Web of Science ®Google Scholar
• Jandeleit-DahmKACalkinATikellisCThomasMDirect antiatherosclerotic effects of PPAR agonistsCurr Opin Lipidol200920242919133407
   PubMed Web of Science ®Google Scholar
• PozziAIbanezMRGaticaAEPeroxisomal proliferator-activated receptor-alpha-dependent inhibition of endothelial cell proliferation and tumorigenesisJ Biol Chem2007282176851769517405874
   PubMed Web of Science ®Google Scholar
• GrabackaMReissKAnticancer properties of PPARalpha – effects on cellular metabolism and inflammationPPAR Res2008930705
   Google Scholar
• ScottRO’BrienRFulcherGEffects of fenofibrate treatment on cardiovascular disease risk in 9,795 individuals with type 2 diabetes and various components of the metabolic syndrome: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) studyDiabetes Care20093249349818984774
   PubMed Web of Science ®Google Scholar
• KasaiTMiyauchiKYokoyamaTAiharaKDaidaHEfficacy of peroxisome proliferative activated receptor (PPAR)-alpha ligands, fenofibrate, on intimal hyperplasia and constrictive remodeling after coronary angioplasty in porcine modelsAtherosclerosis200618827428016325819
   PubMed Web of Science ®Google Scholar
• GizardFAmantCBarbierOPPAR alpha inhibits vascular smooth muscle cell proliferation underlying intimal hyperplasia by inducing the tumor suppressor p16INK4aJ Clin Invest20051153228323816239970
   PubMed Web of Science ®Google Scholar
• BiscettiFGaetaniEFlexASelective activation of peroxisome proliferator-activated receptor (PPAR)alpha and PPAR gamma induces neoangiogenesis through a vascular endothelial growth factor-dependent mechanismDiabetes2008571394140418268046
   PubMed Web of Science ®Google Scholar
• BiscettiFGaetaniEFlexAPeroxisome proliferator-activated receptor alpha is crucial for iloprost-induced in vivo angiogenesis and vascular endothelial growth factor upregulationJ Vasc Res20094610310818617751
   PubMed Web of Science ®Google Scholar
• FauconnetSLascombeIChabannesEDifferential regulation of vascular endothelial growth factor expression by peroxisome proliferator-activated receptors in bladder cancer cellsJ Biol Chem2002277235342354311980898
   PubMed Web of Science ®Google Scholar
• WangNPPAR-delta in Vascular PathophysiologyPPAR Res2008164163
   Google Scholar
• BerryDCNoyNAll-trans-retinoic acid represses obesity and insulin resistance by activating both PPAR{beta}/{delta} and RARMol Cell Biol2009293286329619364826
   PubMed Web of Science ®Google Scholar
• StephenRLGustafssonMCJarvisMActivation of peroxisome proliferator-activated receptor delta stimulates the proliferation of human breast and prostate cancer cell linesCancer Res2004643162317015126355
   PubMed Web of Science ®Google Scholar
• PiquerasLReynoldsARHodivala-DilkeKMActivation of PPARbeta/delta induces endothelial cell proliferation and angiogenesisArterioscler Thromb Vasc Biol200727636917068288
   PubMed Web of Science ®Google Scholar
• GaudelCSchwartzCGiordanoCAbumradNAGrimaldiPAPharmacological activation of PPARbeta promotes rapid and calcineurin-dependent fiber remodeling and angiogenesis in mouse skeletal muscleAm J Physiol Endocrinol Metab2008295E297E30418492772
   PubMed Web of Science ®Google Scholar
• YoshinagaMKitamuraYChaenTThe simultaneous expression of peroxisome proliferator-activated receptor delta and cyclooxygenase-2 may enhance angiogenesis and tumor venous invasion in tissues of colorectal cancersDig Dis Sci2009541108111418720000
   PubMed Web of Science ®Google Scholar
• HeTLuTd’UscioLVLamCFLeeHCKatusicZSAngiogenic function of prostacyclin biosynthesis in human endothelial progenitor cellsCirc Res2008103808818511850
   PubMed Web of Science ®Google Scholar
• Muller-BrusselbachSKomhoffMRieckMDeregulation of tumor angiogenesis and blockade of tumor growth in PPARbeta-deficient miceEmbo J2007263686369817641685
   PubMed Web of Science ®Google Scholar
• MullerRKomhoffMPetersJMMuller-BrusselbachSA Role for PPARbeta/delta in Tumor Stroma and TumorigenesisPPAR Res2008534294
   Google Scholar
• WangDWangHGuoYCrosstalk between peroxisome proliferator-activated receptor delta and VEGF stimulates cancer progressionProc Natl Acad Sci U S A2006103190691907417148604
   PubMed Web of Science ®Google Scholar
• HollingsheadHEKillinsRLBorlandMGPeroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands do not potentiate growth of human cancer cell linesCarcinogenesis2007282641264917693664
   PubMed Web of Science ®Google Scholar
• KimEHSurhYJ15-deoxy-Delta12, 14-prostaglandin J2 as a potential endogenous regulator of redox-sensitive transcription factorsBiochem Pharmacol2006721516152816987499
   PubMed Web of Science ®Google Scholar
• LehmannJMLenhardJMOliverBBRingoldGMKliewerSAPeroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugsJ Biol Chem1997272340634109013583
   PubMed Web of Science ®Google Scholar
• PershadsinghHAPeroxisome proliferator-activated receptor-gamma: therapeutic target for diseases beyond diabetes: quo vadis?Expert Opin Investig Drugs200413215228
   PubMed Web of Science ®Google Scholar
• GiaginisCTsantili-KakoulidouATheocharisSPeroxisome proliferator-activated receptor-gamma ligands: potential pharmacological agents for targeting the angiogenesis signaling cascade in cancerPPAR Res2008431763
   Google Scholar
• RosmarakisESFalagasMEEffect of thiazolidinedione therapy on restenosis after coronary stent implantation: a meta-analysis of randomized controlled trialsAm Heart J200715414415017584567
   PubMed Web of Science ®Google Scholar
• DesouzaCVGeretyMHamelFGLong-term effects of a PPAR-gamma agonist, pioglitazone, on neointimal hyperplasia and endothelial regrowth in insulin resistant ratsVascul Pharmacol20074618819417141574
   PubMed Web of Science ®Google Scholar
• PanigrahyDSingerSShenLQPPARgamma ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesisJ Clin Invest200211092393212370270
   PubMed Web of Science ®Google Scholar
• SheuWHOuHCChouFPLinTMYangCHRosiglitazone inhibits endothelial proliferation and angiogenesisLife Sci2006781520152816297938
   PubMed Web of Science ®Google Scholar
• Bishop-BaileyDHlaTEndothelial cell apoptosis induced by the peroxisome proliferator-activated receptor (PPAR) ligand 15-deoxy-Delta12, 14-prostaglandin J2J Biol Chem1999274170421704810358055
   PubMed Web of Science ®Google Scholar
• GiriSRattanRSinghAKSinghIThe 15-deoxy-delta12,14-prostaglandin J2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-kappaB- p300 pathway independent of peroxisome proliferator-activated receptor gammaJ Immunol20041735196520815470065
   PubMed Web of Science ®Google Scholar
• AljadaAO’ConnorLFuYYMousaSAPPAR gamma ligands, rosiglitazone and pioglitazone, inhibit bFGF- and VEGF-mediated angiogenesisAngiogenesis20081136136718810647
   PubMed Web of Science ®Google Scholar
• ChoDHChoiYJJoSAJoINitric oxide production and regulation of endothelial nitric-oxide synthase phosphorylation by prolonged treatment with troglitazone: evidence for involvement of peroxisome proliferator-activated receptor (PPAR) gamma-dependent and PPARgamma-independent signaling pathwaysJ Biol Chem20042792499250614593122
   PubMed Web of Science ®Google Scholar
• ChintalgattuVHarrisGSAkulaSMKatwaLCPPAR-gamma agonists induce the expression of VEGF and its receptors in cultured cardiac myofibroblastsCardiovasc Res20077414015017320065
   PubMed Web of Science ®Google Scholar
• GealekmanOBurkartAChouinardMNicoloroSMStraubhaarJCorveraSEnhanced angiogenesis in obesity and in response to PPAR-gamma activators through adipocyte VEGF and ANGPTL4 productionAm J Physiol Endocrinol Metab2008295E1056E106418728224
   PubMed Web of Science ®Google Scholar
• ChuKLeeSTKooJSPeroxisome proliferator-activated receptor-gamma-agonist, rosiglitazone, promotes angiogenesis after focal cerebral ischemiaBrain Res2006109320821816696956
   PubMed Web of Science ®Google Scholar
• HuangPHSataMNishimatsuHSumiMHirataYNagaiRPioglitazone ameliorates endothelial dysfunction and restores ischemia-induced angiogenesis in diabetic miceBiomed Pharmacother200862465217692499
   PubMed Web of Science ®Google Scholar
• GenschCCleverYPWernerCHanhounMBohmMLaufsUThe PPAR-gamma agonist pioglitazone increases neoangiogenesis and prevents apoptosis of endothelial progenitor cellsAtherosclerosis2007192677416876172
   PubMed Web of Science ®Google Scholar
• VijaySKMishraMKumarHTripathiKEffect of pioglitazone and rosiglitazone on mediators of endothelial dysfunction, markers of angiogenesis and inflammatory cytokines in type-2 diabetesActa Diabetol200946273318758684
   PubMed Web of Science ®Google Scholar
• FongDSContrerasRGlitazone use associated with diabetic macular edemaAm J Ophthalmol2009147583586e119181303
   PubMed Web of Science ®Google Scholar
• FinckBNKellyDPPeroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) regulatory cascade in cardiac physiology and diseaseCirculation20071152540254817502589
   PubMed Web of Science ®Google Scholar
• AranyZFooSYMaYHIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alphaNature20084511008101218288196
   PubMed Web of Science ®Google Scholar
• HickeyMMSimonMCRegulation of angiogenesis by hypoxia and hypoxia-inducible factorsCurr Top Dev Biol20067621725717118268
   PubMed Web of Science ®Google Scholar
• LeeKSKimSRParkSJPeroxisome proliferator activated receptor-gamma modulates reactive oxygen species generation and activation of nuclear factor-kappaB and hypoxia-inducible factor 1alpha in allergic airway disease of miceJ Allergy Clin Immunol200611812012716815147
   PubMed Web of Science ®Google Scholar
• ChenJCuiXZacharekARobertsCChoppMeNOS mediates TO90317 treatment-induced angiogenesis and functional outcome after stroke in miceStroke2009402532253819443804
   PubMed Web of Science ®Google Scholar
• HowellKCostelloCMSandsMDooleyIMcLoughlinPL-arginine promotes angiogenesis in the chronically hypoxic lung: a novel mechanism ameliorating pulmonary hypertensionAm J Physiol Lung Cell Mol Physiol2009296L1042L105019346433
   PubMed Web of Science ®Google Scholar
• NamkoongSKimCKChoYLForskolin increases angiogenesis through the coordinated cross-talk of PKA-dependent VEGF expression and Epac-mediated PI3K/Akt/eNOS signalingCell Signal20092190691519385062
   PubMed Web of Science ®Google Scholar
• YasudaSKobayashiHIwasaMAntidiabetic drug pioglitazone protects the heart via activation of PPAR-{gamma} receptors, PI3-kinase, Akt, and eNOS pathway in a rabbit model of myocardial infarctionAm J Physiol Heart Circ Physiol2009296H1558H156519286954
   PubMed Web of Science ®Google Scholar
• BulhakAAJungCOstensonCGLundbergJOSjoquistPOPernowJPPAR-alpha activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-Kinase/Akt and NO pathwayAm J Physiol Heart Circ Physiol2009296H719H72719151258
   PubMed Web of Science ®Google Scholar
• CuzzocreaSPisanoBDugoLRosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute inflammationEur J Pharmacol2004483799314709329
   PubMed Web of Science ®Google Scholar
• TaoLLiuHRGaoEAntioxidative, antinitrative, and vasculoprotective effects of a peroxisome proliferator-activated receptor-gamma agonist in hypercholesterolemiaCirculation20031082805281114610009
   PubMed Web of Science ®Google Scholar
• PedchenkoTVGonzalezALWangDDuBoisRNMassionPPPeroxisome proliferator-activated receptor beta/delta expression and activation in lung cancerAm J Respir Cell Mol Biol20083968969618566335
   PubMed Web of Science ®Google Scholar
• MaJSawaiHOchiNPTEN regulate angiogenesis through PI3K/Akt/VEGF signaling pathway in human pancreatic cancer cellsMol Cell Biochem2009 May 13 Epub ahead of print
   Web of Science ®Google Scholar
• PanigrahyDKaipainenAHuangSPPARalpha agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibitionProc Natl Acad Sci U S A200810598599018199835
   PubMed Web of Science ®Google Scholar
• MinutoliLAntonuccioPPolitoFPeroxisome proliferator activated receptor beta/delta activation prevents extracellular regulated kinase 1/2 phosphorylation and protects the testis from ischemia and reperfusion injuryJ Urol20091811913192119237170
   PubMed Web of Science ®Google Scholar
• LimHJLeeSParkJHPPAR delta agonist L-165041 inhibits rat vascular smooth muscle cell proliferation and migration via inhibition of cell cycleAtherosclerosis200920244645418585719
   PubMed Web of Science ®Google Scholar
• BorlandMGForemanJEGirroirEELigand activation of peroxisome proliferator-activated receptor-beta/delta inhibits cell proliferation in human HaCaT keratinocytesMol Pharmacol2008741429144218687807
   PubMed Web of Science ®Google Scholar
• PiquerasLSanzMJPerrettiMActivation of PPAR{beta}/{delta} inhibits leukocyte recruitment, cell adhesion molecule expression, and chemokine releaseJ Leukoc Biol20098611512219389799
   PubMed Web of Science ®Google Scholar